Kiora Pharmaceuticals Eulerpool Ziņas

Kiora Pharmaceuticals Eulerpool News

Kiora Pharmaceuticals Akciju Ziņas

Kiora Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Kiora Pharmaceuticals ziņas mēs apkopojam šeit.

• 25. septembris ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• 12. augusts ·

  Thefly.com
  Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
• 10. augusts ·

  TipRanks
  Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
• 9. augusts ·

  Yahoo
  Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
• 9. augusts ·

  Seeking Alpha
  Kiora Pharmaceuticals GAAP EPS of -$0.53 beats by $0.33
• 9. augusts ·

  InvestorPlace
  KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024
• 6. augusts ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• 30. jūlijs ·

  Yahoo
  Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies
• 22. jūlijs ·

  TipRanks
  Buy Rating Affirmed for Kiora Pharmaceuticals Amid Strategic Enhancements and Clinical Progress
• 10. jūlijs ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation